Clinical significance of pentraxin-3 and C-reactive protein in the differentiation of stages of nonalcoholic fatty liver disease
| dc.contributor.author | Aleksandrova, Tetiana | |
| dc.contributor.author | Dhainy, Ali | |
| dc.contributor.author | Isam, Mohamed | |
| dc.date.accessioned | 2021-11-08T09:02:52Z | |
| dc.date.available | 2021-11-08T09:02:52Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder . It encompasses a range of conditions from hepatic steatosis to cirrhosis and liver cancer. In patients with NAFLD, the progression from simple steatosis to Non alcoholic steatohepatitis and cirrhosis is characterized by cellular injury from oxidative stress and cytokine-driven intrahepatic inflammation . There are studies suggesting that the intrahepatic inflammation associated with NAFLD may be linked to systemic elevations in inflammatory biomarkers, such as C-reactive protein (CRP) and novel marker for NASH - Pentraxin-3 | en_US |
| dc.identifier.citation | Dhainy A. Clinical significance of pentraxin-3 and C-reactive protein in the differentiation of stages of nonalcoholic fatty liver disease / A. Dhainy, I. Mohamed, T. Aleksandrova // ISIC-2021 : [International Scientific Interdisciplinary Conference for medical students and young scientists, Kharkiv, 20–21 october, 2021] : abstract book / KNMU. – Kharkiv, 2021. – Р. 72–73. | en_US |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/29552 | |
| dc.language.iso | en | en_US |
| dc.subject | non-alcoholic fatty liver disease | en_US |
| dc.subject | C-reactive protein | en_US |
| dc.subject | Pentraxin-3 | en_US |
| dc.subject | hepatic steatosis | en_US |
| dc.title | Clinical significance of pentraxin-3 and C-reactive protein in the differentiation of stages of nonalcoholic fatty liver disease | en_US |
| dc.type | Thesis | en_US |